▲ Peaking
Business
FDA Approves Centanafadine for ADHD in Children, Adolescents, and Adults
The FDA has approved Otsuka's Simtriyo (centanafadine), the first new-class ADHD medication for pediatric and adult patients in decades.
1 trends tracked about this subject — the full history, oldest to newest below.
The FDA has approved Otsuka's Simtriyo (centanafadine), the first new-class ADHD medication for pediatric and adult patients in decades.